经皮冠状动脉介入治疗后普伐他汀对血清基质金属蛋白酶水平的影响

, PP. 2096-2098

Keywords: PCI,普伐他汀,冠状动脉疾病

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]

李飞飞，李莉，刘秋慧，等. 经皮冠状动脉介入治疗后普伐他汀对血清基质金属蛋白酶水平的影响[J]. 第三军医大学学报,2006,28(20):2096-2098.

[2]

邹凡文,鲁力,周建中,等.血脂康、普伐他汀对高血压病患者血清中NO、ET、hs-CRP、IL-1和TNF-α水平的干预效应[J].第三军医大学学报,2009,31(24):2478. 　ZOU Fan-wen,LU Li,ZHOU Jian-zhong,et al.Interventional effects of natural or chemosynthesis statin on serum NO, ET, hs-CRP, IL-1 and TNF-α in simple essential hypertensive patients[J].J Third Mil Med Univ,2009,31(20):2478. [2]刘廷容,佘强,吴雪晖.大鼠心肌梗死后HCN表达的变化及普伐他汀的干预[J].第三军医大学学报,2008,30(14):1346. 　LIU Ting-rong,SHE Qiang,WU Xue-hui.Effect of pravastatin on expression of HCN channel in post-myocardial infarction rats[J].J Third Mil Med Univ,2008,30(20):1346.

Full-Text